New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells
Eva Gottfried(University of Regensburg), Marina Kreutz(University Hospital Regensburg)
Cited by 118
Related Papers
Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
|Frontiers in Immunology|2017|367
D-2-Hydroxyglutarate and L-2-Hydroxyglutarate Inhibit IL-12 Secretion by Human Monocyte-Derived Dendritic Cells
|International Journal of Molecular Sciences|2019|27
LDHB Overexpression Can Partially Overcome T Cell Inhibition by Lactic Acid
|International Journal of Molecular Sciences|2022|27
D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells
|Haematologica|2024|13
Physiological levels of 25‐hydroxyvitamin D<sub>3</sub> induce a suppressive CD4<sup>+</sup> T cell phenotype not reflected in the epigenetic landscape
|Scandinavian Journal of Immunology|2022|7